Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Regeneron

Mentioned in 2 analyzed podcast episodes across 2 shows

Episode Mentions

Squawk Pod

Squawk Pod · Apr 24, 2026

David Sacks, Anthropic, & the White House, Regeneron’s Deafness Cure 4/24/26

FDA approved Otarmony gene therapy for genetic deafness; offering treatment free to U.S. patients; negotiated drug pricing deal with Trump administration

AI Chip Demand and Semiconductor SupplyGovernment AI Procurement and Use RestrictionsAI Model Bias and Political Alignment
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 24, 2026

Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

Achieved FDA approval for Otarmini, a gene therapy for hearing loss, using the National Priority Voucher Program

Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes
View Analysis